CRISPR/Cas9-mediated gene knockout for DNA methyltransferase Dnmt3a in CHO cells displays enhanced t

来源 :中国生物化学与分子生物学会2019年全国学术会议 | 被引量 : 0次 | 上传用户:hf2562
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  DNA methyltransferase Dnmt3a was knocked out by CRISPR/Cas9 technology to construct Dnmt3a-deficient CHO cell expression system.
其他文献
As an incretin used to treat type 2 diabetes,glucagon-like peptide 1(GLP-1)improves cardiovascular diseases by regulating the heart rate and blood pressure and ameliorating endothelial function and va
Type-2 diabetes is a metabolic disease.This study has revealed that the activity of serum thioredoxin(Trx)appears as a good biomarker for type-2 diabetes.
Non-muscular myosin heavy chain IIA(NMMHC IIA)plays a key role in tissue factor expression and venous thrombosis.Natural products might inhibit thrombosis through effects on NMMHC IIA.
Anthrax lethal toxin(LT)is known to induce NLRP1B inflammasome activation and pyroptotic cell death in macrophages from certain mouse strains in its metalloprotease activity-dependent manner,but the u
Indian hedgehog(Ihh)is a highly conserved secreted signaling protein involved in regulating cartilage formation and development.
TCAB1(Telomere Cajal Body protein 1)is an important component of Cajal body.It participates in telomere elongation,repairs DNA double strands break and promotes tumor development.
Hepatitis B virus(HBV)is a major public health threat and leading to end-stage liver diseases,such as hepatitis and hepatocellular carcinoma.
Anaplastic thyroid cancer(ATC)is the most aggressive human thyroid malignancy,characterized by dedifferentiation and resistance to radioiodine therapy.
Malignant tumors are serious diseases that seriously threaten human health.The treatment is mainly based on surgical treatment,radiation therapy,chemotherapy and immunotherapy in recent years.